This article has been cited by other articles in PMC.
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (192K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
Heckmatt J, Hasson N, Saunders C, Thompson N, Peters AM, Cambridge G, Rose M, Hyde SA, Dubowitz V. Cyclosporin in juvenile dermatomyositis. Lancet. 1989 May 13;1(8646):1063–1066.[PubMed]
van der Meer S, Imhof JW, Borleffs JC. Cyclosporin for polymyositis. Ann Rheum Dis. 1986 Jul;45(7):612–612.[PMC free article][PubMed]
Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med. 1989 Jul 15;111(2):143–157.[PubMed]
Colombani PM, Hess AD. T-lymphocyte inhibition by cyclosporine. Potential mechanisms of action. Biochem Pharmacol. 1987 Nov 15;36(22):3789–3793.[PubMed]
Dawkins RL, Mastaglia FL. Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med. 1973 Mar 1;288(9):434–438.[PubMed]
Penn I. Cyclosporine and oncogenesis. Mt Sinai J Med. 1987 Sep;54(6):460–464.[PubMed]
Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press